Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.21.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Summary of Assumptions Used to Determine Fair Value of Options

The range of assumptions that the Company used to determine the grant date fair value of employee and director options granted were as follows:

 

 

Three months ended

 

 

 

March 31, 2020

 

Volatility

 

90.3%

 

Expected term in years

 

 

6.25

 

Dividend rate

 

0%

 

Risk-free interest rate

 

0.78%

 

Share price

 

$2.03

 

Fair value of option on grant date

 

$1.52

 

Summary of Number of Options Outstanding and Weighted-average Exercise Price

The following table summarizes the number of options outstanding and the weighted-average exercise price as of March 31, 2021:

 

 

Number of

Shares

 

 

Weighted

Average Exercise

Price

 

 

Weighted

Average

Remaining

Contractual Life

in Years

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Options outstanding December 31, 2020

 

 

953,377

 

 

$

7.36

 

 

 

5.41

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(262,644

)

 

$

8.55

 

 

 

 

 

 

 

 

 

Options outstanding March 31, 2021

 

 

690,733

 

 

$

6.91

 

 

 

7.14

 

 

$

 

Exercisable at March 31, 2021 (unaudited)

 

 

455,088

 

 

$

7.35

 

 

 

6.69

 

 

$

 

Summary of Number of RSUs Outstanding and Weighted-average Grant Date Fair Value of RSUs

The table below shows the number of RSUs outstanding covering an equal number of the Company’s ordinary shares and the weighted-average grant date fair value of the RSUs outstanding as of March 31, 2021:

 

 

Number of

Shares

 

 

Weighted Average

Grant Date Fair

Value per Share

 

RSUs outstanding December 31, 2020

 

 

 

 

 

 

 

Granted

 

 

1,198,136

 

 

$

1.60

 

Shares vested

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

RSUs outstanding March 31, 2021

 

 

1,198,136

 

 

$

1.60

 

 

Summary of Share-based Compensation Expense

The Company’s share-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

 

 

(unaudited)

 

Research and development expense

 

$

9

 

 

$

213

 

General and administrative expense

 

 

272

 

 

 

384

 

Performance RSUs  
Summary of Number of RSUs Outstanding and Weighted-average Grant Date Fair Value of RSUs

The table below shows the number of Performance RSUs outstanding covering an equal number of the Company’s ordinary shares and the weighted-average grant date fair value of the Performance RSUs outstanding as of March 31, 2021:

 

 

Number of

Shares

 

 

Weighted Average

Grant Date Fair

Value per Share

 

Performance RSUs outstanding December 31, 2020

 

 

983,000

 

 

$

2.20

 

Granted

 

 

 

 

 

 

 

Shares vested

 

 

(478,500

)

 

$

2.08

 

Expired

 

 

(97,500

)

 

$

2.08

 

Performance RSUs outstanding March 31, 2021

 

 

407,000

 

 

$

2.40